fap dna vaccine (Syncon Inc)
90
Structured Review
Syncon Inc
fap dna vaccine
Fap Dna Vaccine, supplied by Syncon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fap+dna+vaccine/syncon+fap+vaccine/pm39892648-182-6-6
Average 90 stars, based on 1 article reviews
Fap Dna Vaccine, supplied by Syncon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fap+dna+vaccine/syncon+fap+vaccine/pm39892648-182-6-6
Average 90 stars, based on 1 article reviews
fap dna vaccine - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Modification:Article Title: Effective design of therapeutic nanovaccines based on tumor neoantigens. Article Snippet: Neoantigen vaccines are among the most potent immunotherapies for personalized cancer treatment.. Therapeutic vaccines containing tumor-specific neoantigens that elicit specific T cell responses offer the potential for long-term clinical benefits to cancer patients.. Unlike immune-checkpoint inhibitors (ICIs), which rely on preexisting specific T cell responses, personalized neoantigen vaccines not only promote existing specific T cell responses but importantly stimulate the generation of neoantigen-specific T cells, leading to the establishment of a persistent specific memory T cell pool. Vaccines:Article Title: Effective design of therapeutic nanovaccines based on tumor neoantigens. Article Snippet: Neoantigen vaccines are among the most potent immunotherapies for personalized cancer treatment.. Therapeutic vaccines containing tumor-specific neoantigens that elicit specific T cell responses offer the potential for long-term clinical benefits to cancer patients.. Unlike immune-checkpoint inhibitors (ICIs), which rely on preexisting specific T cell responses, personalized neoantigen vaccines not only promote existing specific T cell responses but importantly stimulate the generation of neoantigen-specific T cells, leading to the establishment of a persistent specific memory T cell pool. Article Title: Research progress in tumor targeted immunotherapy. Article Snippet: Introduction: Compared with traditional cancer treatment methods, tumor-targeted immunotherapy can combine targeted therapy and immunotherapy with long-lasting responses to achieve synergistic therapy, which brings hope to the complete cure of cancer.. Areas covered: This review summarizes the newest and most up-to-date advances in tumor-targeted immunotherapy, including tumor-associated macrophages (TAMs) targeted immunotherapy, regulatory T (Treg) cells targeted immunotherapy, tumor-associated fibroblasts (TAFs) targeted immunotherapy and immune checkpoints targeted immunotherapy.. Expert opinion: Immunotherapy can restore anti-tumor immunity in the tumor microenvironment and produce a lasting immune surveillance effect. Article Title: Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Article Snippet: Recently, a synthetic consensus (SynCon) FAP DNA vaccine has displayed superiority at breaking immune tolerance compared to the native FAP immunogen in genetically diverse mice. .. The Biomarker Discovery:Article Title: Effective design of therapeutic nanovaccines based on tumor neoantigens. Article Snippet: Neoantigen vaccines are among the most potent immunotherapies for personalized cancer treatment.. Therapeutic vaccines containing tumor-specific neoantigens that elicit specific T cell responses offer the potential for long-term clinical benefits to cancer patients.. Unlike immune-checkpoint inhibitors (ICIs), which rely on preexisting specific T cell responses, personalized neoantigen vaccines not only promote existing specific T cell responses but importantly stimulate the generation of neoantigen-specific T cells, leading to the establishment of a persistent specific memory T cell pool. Immunopeptidomics:Article Title: Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice Article Snippet: .. © 2017 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 8 Immunogenicity of Injection:Article Title: Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice Article Snippet: .. © 2017 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 8 Immunogenicity of Activity Assay:Article Title: Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Article Snippet: Recently, a synthetic consensus (SynCon) FAP DNA vaccine has displayed superiority at breaking immune tolerance compared to the native FAP immunogen in genetically diverse mice. .. The other:Article Title: Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice Article Snippet: While variability was observed between the mice, the overall immune response was higher for the |